April 25th 2024
In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
FDA Requires All US Blood Donations Be Tested for Zika Virus
August 29th 2016On Friday, August 26, 2016, the FDA amended its blood collection guidance, stating that all blood donations in US states and territories be tested for Zika virus infection, to ensure the safety of the nation’s blood supply.
Read More
Severity of Zika Threat Still Open for Debate—US Health Officials Not Taking Any Chances
August 25th 2016With 43 “local” cases of Zika virus infection now reported in Florida, and as far north as St. Petersburg, health officials in other Gulf states are ramping up responses in the event of potential outbreaks—even as there remains some disagreement as to the true nature of the threat of local transmission in the United States.
Read More
Two Novel Biomarkers Associated with Clinical Outcome in Dengue
August 22nd 2016Researchers analyzed soluble forms of the B cell antigens CD27 and CD38 (sCD27 and sCD38, respectively) in the plasma of children with dengue and have suggested a role for these soluble forms as biomarkers of progression of the disease.
Read More
Scientists Identify Zika Proteins Causing Microcephaly
August 18th 2016In the first research of its kind, an interdisciplinary group of scientists analyzed three Zika strains in second trimester fetal neural stem cells (fNSC) to identify which viral proteins cause congenital microcephaly. Since Zika causes significant neurological impairment, early diagnosis is imperative.
Read More
Increasing Zika Transmission in Puerto Rico and Florida Prompts Additional CDC Funding
August 2nd 2016The rapid spread of Zika throughout Puerto Rico coupled with the introduction of active transmission in Florida has prompted the Centers for Disease Control and Prevention (CDC) to award millions in Zika funding to US states and territories.
Read More
Yellow Fever Vaccine Enters Clinical Trial
July 29th 2016In response to the growing outbreak, and the escalating need for a vaccine that can be used in infants, those who are immunocompromised, and other populations in whom currently available vaccines are not to be administered, the NIAID has entered a vaccine manufactured by Bavarian Nordic into Phase I trials.
Read More
Possible Active Zika Transmission in US Under Investigation as CDC Updates Guidelines
July 28th 2016After failed requests for funding and warnings of the inevitable, the Florida Department of Health is investigating what could be the first cases of active Zika Transmission in the United States.
Read More
Infectious Aortitis and Mycotic Abdominal Aneurysm Secondary to Cat Bite Injury
July 24th 2016A recent report describes a case of infectious aortitis and resultant mycotic abdominal aneurysm that arose as rare complications of exposure to Pasteurella multocida from a cat bite in a male patient.
Read More
Zika Virus Mapped from Mother to Fetus
July 22nd 2016Researchers from the University of California-San Francisco (UCSF) have provided a roadmap for how the Zika virus travels from the blood of an infected pregnant woman to her fetus, providing new clues to the process by which the disease leads to birth defects.
Read More